Report : North America Poultry Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Broiler, Layer, and Breeder), Technology (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Others), Dosage Form (Liquid vaccines, Freeze-Dried Vaccines, and Dust/Powdered Vaccines), Disease [Newcastle Disease, Avian Influenza, Marek's Disease, Infectious Bronchitis (IB), Infectious Bursal Disease (IBD), Salmonellosis, and Others], Route of Administration [Drinking Water (D/W) and Spray, Intramuscular (I/M), Subcutaneous (S/C), and Others], and End User (Poultry Farms and Hatcheries, Veterinary Hospitals, and Poultry Vaccination Centers and Clinics)
Liquid vaccines Segment to Dominate North America Poultry Vaccines market Forecast to 2028 during 2019–2028
According to a new market research study on the North America Poultry Vaccines market Forecast to 2028 –– by type, technology, dosage form, disease, route of administration, end user and countries is expected to reach US$ 1,256.14 million by 2028 from US$ 808.91 million in 2021. The market is estimated to grow at a CAGR of 6.5% from 2021 to 2028. The report provides trends prevailing in the North America Poultry Vaccines market along with the drivers and restraints pertaining to the market growth. Increasing prevalence of diseases in poultry is the major factor driving the growth of the North America Poultry Vaccines market. However, issues failure of vaccines in poultry production the growth of North America Poultry Vaccines market.
The North America Poultry Vaccines market segmented into by type, technology, dosage form, disease, route of administration, end user and countries. Based on type the North America Poultry Vaccines market is segmented into broiler, layer, and breeder. The breeder segment is dominated North America Poultry Vaccines market in 2020. Based on technology the North America Poultry Vaccines market segmented into live attenuated vaccines, inactivated vaccines, recombinant vaccines, and others. The live attenuated vaccines segment North America Poultry Vaccines market Dominated in 2020. Based on dosage form the North America Poultry Vaccines market segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered vaccines. The liquid vaccines segment is dominated North America Poultry Vaccines market in 2020. Based on disease the North America Poultry Vaccines market segmented into newcastle disease, avian influenza, marek's disease, infectious bronchitis (ib), infectious bursal disease (ibd), salmonellosis, and others. The newcastle disease is dominated the North America Poultry Vaccines market in 2020. Based on route of administration the North America Poultry Vaccines market segmented into drinking water (d/w) and spray, intramuscular (i/m), subcutaneous (s/c) and others. The drinking water (d/w) and spray is dominated the North America Poultry Vaccines market in 2020. Based on end user the North America Poultry Vaccines market segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination centers & clinics. The poultry farms & hatchery is dominated the North America Poultry Vaccines market in 2020. Based on country The North America Poultry Vaccines market segmented into US, Mexico, Canada. The US is dominated the North America Poultry Vaccines market in 2020.
Boehringer Ingelheim Intrnational GmbH, Zoitis Inc., Ceya Santae Animale, BIOVAC, PHIBRO ANIMAL HEALTH CORPORATION, Hester Biosciences Limited, Dechra Pharmaceutical Plc, Elanco and Merck Animal Health are among the leading companies in North America Poultry Vaccines market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in dynamic market.
Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email Id: sales@businessmarketinsights.com